Cent Eur J Public Health 2010, 18(2):104-109 | DOI: 10.21101/cejph.a3576

Seroprevalence of Blood-borne Infections and Population Sizes Estimates in a Population of Injecting Drug Users in Croatia

Branko Kolarić1, Dinko Štajduhar2, Davorin Gajnik1, Tomislav Rukavina3, Lucas Wiessing4
1 Public Health, Social Medicine and Gerontology Service, Zagreb County Institute of Public Health, Zagreb, Croatia
2 Neuropsychiatric Hospital "Dr. Ivan Brbot", Popovača, Croatia
3 School of Medicine, University of Rijeka, Rijeka, Croatia
4 European Monitoring Center for Drugs and Drug Addiction, Lisbon, Portugal

Similar to some other Central European countries, Croatia has low HIV prevalence among injecting drug users (IDUs) but high hepatitis C (HCV) prevalence. This may indicate different patterns of risk behaviour in this region than in other parts of Europe. The main objectives of this study were to assess the seroprevalence of HIV and hepatitis B and C and related risk factors among IDUs in the three largest Croatian cities (Zagreb, Split, Rijeka) and within the national prison system, as well as to apply a multiplier-method population size estimation of IDUs in Zagreb, Split and Rijeka. Recruitment sites were selected in collaboration with the local public health institutes, NGOs, Centers for treatment municipalities and the judiciary system. Participants were recruited during September and October 2007. Trained peer-recruiters were used to recruit IDU participants at treatment and harm reduction centres as well as pre-identified social, commercial and street based venues. Participants completed the study questionnaire and provided venous blood samples for HIV, hepatitis B and hepatitis C testing. The study included 601 participants, of whom 121 were recruited in Split, 130 in Zagreb, 150 in Rijeka and 200 in the prison system. The prevalence of positive anti-HCV tests was 65% in Split, 51% in Zagreb, 29% in Rijeka and 44% in the prisons. The prevalence of anti-HBcAg was 31% in Split, 13% in Zagreb, 9% in Rijeka and 24% in prison. No case of HIV infection was found. The estimated population sizes were 2,805 for Zagreb area, 3,347 for Split and 1,370 for Rijeka area, however confidence intervals were very large, indicating the need for larger samples. A high frequency of positive markers on hepatitis B virus and C virus in the population of injecting drug users in Croatia has been confirmed with this research, as well as a low prevalence of HIV infection. This may be related to relatively low levels of injecting risk behaviour and injecting frequency although it is not possible to make strong conclusions on risk behaviour, as participants were mostly recruited in harm reduction programmes. This research should be followed by targeted activities for reducing risks of infectious diseases among injecting drug users in the Republic of Croatia and future research at the national level.

Klíčová slova: injecting drug use, Croatia, size estimate, HIV, hepatitis, prevalence

Vloženo: 2. červenec 2009; Revidováno: 11. listopad 2009; Přijato: 11. listopad 2009; Zveřejněno: 1. červen 2010  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kolarić B, Štajduhar D, Gajnik D, Rukavina T, Wiessing L. Seroprevalence of Blood-borne Infections and Population Sizes Estimates in a Population of Injecting Drug Users in Croatia. Cent Eur J Public Health. 2010;18(2):104-109. doi: 10.21101/cejph.a3576. PubMed PMID: 20939261.
Sdílet...
Stáhnout citaci
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobrazit celý článek

    Reference

    1. HIV/AIDS data and statistics [Internet]. Geneva: World Health Organization [cited 2009 Aug]. Available from: http://www.who.int/hiv/data/en/
    2. Report on the global HIV/AIDS epidemic 2008: executive summary [Internet]. Geneva: UNAIDS [cited 2009 Aug]. Available from: http://data.unaids.org/pub/GlobalReport/2008/JC1511_GR08_ExecutiveSummary_en.pdf.
    3. Mathers B, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al; 2007 Reference Group to the UN on HIV and Injecting Drug Use. Global epidemiology of injecting drug use and HIV among people who inject drugs: a review. Lancet. 2008 Nov 15;372(9651):1733-45. Přejít k původnímu zdroji... Přejít na PubMed...
    4. Wiessing L, Likatavičius G, Klempová D, Hedrich D, Nardone A, Griffiths P.Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users. Am J Public Health. 2009 Jun;99(6):1049-52. Přejít k původnímu zdroji... Přejít na PubMed...
    5. European Monitoring Centre for Drugs and Drug Addiction. Annual Report 2007: the state of the drugs problem in the European Union [Internet]. Luxembourg: Office for Official Publications of the European Communities; 2007 [cited 2008 Sep 22]. Available from: http://www.emcdda.europa.eu/publications/annual-report/2007.
    6. Gyarmathy VA, Neaigus A. Marginalized and socially integrated groups of IDUs in Hungary: potential bridges of HIV infection. J Urban Health. 2005 Sep;82(3 Suppl 4):101-12. Přejít k původnímu zdroji... Přejít na PubMed...
    7. Croatian National Institute of Public Health. Report on treatment of drug users in Croatia in 2005. Zagreb: Croatian National Institute of Public Health; 2006. (In Croatian.)
    8. Kolaric B, Pavlic J. HIV/AIDS surveillance in Croatia. Zagreb (CRO): Croatian National Institute of Public Health; 2007.
    9. Family Health International [Internet]. Arlington: FHI [cited 2007 Mar]. Available from: http://www.fhi.org/en.
    10. European Monitoring Centre for Drugs and DrugAddiction. Protocol for the implementation of the EMCDDA key Indicator Drug Related Infectious Diseases (DRID). Draft Version 6 October 2006. Project CT.04. P1.337 [Internet]. Lisbon: EMCDDA; 2006 [cited 2009 Jun 2].Available from: http://www.emcdda.europa.eu/themes/key-indicators/drid.
    11. Weber B. A new automated fourth-generation HIV screening assay with sensitive antigen detection module and high specificity. Methods Mol Biol. 2005;304:245-55. Přejít k původnímu zdroji... Přejít na PubMed...
    12. Lakshmi V, Ponamgi SP. Evaluation of an indigenous western blot kit for human immunodeficiency virus. Indian J Med Microbiol. 2002 OctDec;20(4):200-5. Přejít k původnímu zdroji...
    13. Downie JC, Howard R, Bowcock B, Cunningham AL. HIV-1 antibody testing strategy: evaluation of ELISAscreening and western blot profiles in a mixed low risk/high risk patient population. J Virol Methods. 1989 Dec;26(3):291-303. Přejít k původnímu zdroji... Přejít na PubMed...
    14. Friedman SR, Tempalski B, Cooper H, Perlis T, Keem M, Friedman R, et al. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health. 2004 Sep;81(3):377-400. Přejít k původnímu zdroji... Přejít na PubMed...
    15. Zhang D, Wang L, Lv F, Su W, LiuY, Shen R, et al.Advantages and challenges of using census and multiplier methods to estimate the number of female sex workers in a Chinese city. AIDS Care. 2007 Jan;19(1):17-9. Přejít k původnímu zdroji... Přejít na PubMed...
    16. European Monitoring Centre for Drugs and Drug Addiction. Annual report 2007. Lisbon: EMCDDA; 2007.
    17. European Centre for Disease Prevention and Control. HIV/AIDS surveillance in Europe report 2007. Stockholm: ECDC; 2008.
    18. Sanchez JL, Todd CS, Bautista CT, Botros BA, Khakimov MM, Giyasova GM, et al. High HIV prevalence and risk factors among injection drug users in Tashkent, Uzbekistan, 2003-2004. Drug Alcohol Depend. 2006 Apr;82 Suppl 1:15-22. Přejít k původnímu zdroji...
    19. Abdala N, Krasnoselskikh TV, DuranteAJ, Timofeeva MY, Verevochkin SV, Kozlov AP. Sexually transmitted infections, sexual risk behaviors and the risk of heterosexual spread of HIV among and beyond IDUs in St. Petersburg, Russia. Eur Addict Res. 2008;14(1):19-25. Přejít k původnímu zdroji... Přejít na PubMed...
    20. Rácz J, Gyarmathy VA, NeaigusA, Ujhelyi E. Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest. AIDS Care. 2007 Jan;19(1):59-66. Přejít k původnímu zdroji... Přejít na PubMed...
    21. Stark K, Sieroslawski J, Müller R, Wirth D, Godwod-Sikorska C, Bienzle U. Determinants of current HIV risk behaviour among injecting drug users in Warsaw, Poland. Eur J Epidemiol. 1996 Jun;12(3):315-7. Přejít k původnímu zdroji...
    22. Stark K, Herrmann U, Ehrhardt S, Bienzle U. A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany. Epidemiol Infect. 2006 Aug;134(4):814-9. Přejít k původnímu zdroji... Přejít na PubMed...
    23. Vidal-Trecan GM, Varescon-Pousson I, Boissonnas A. Injection risk behaviors at the first and at the most recent injections among drug users. Drug Alcohol Depend. 2002 Apr 1;66(2):107-9. Přejít k původnímu zdroji...
    24. Valenciano M, Emmanuelli J, Lert F. Unsafe injecting practices among attendees of syringe exchange programmes in France. Addiction. 2001 Apr;96(4):597-606. Přejít k původnímu zdroji...
    25. Gattari P, Spizzichino L, Valenzi C, Zaccarelli M, Rezza G. Behavioural patterns and HIV infection among drug using transvestites practising prostitution in Rome. AIDS Care. 1992;4(1):83-7. Přejít k původnímu zdroji... Přejít na PubMed...
    26. Ehrenstein V, Horton NJ, Samet JH. Inconsistent condom use among HIV-infected patients with alcohol problems. Drug Alcohol Depend. 2004 Feb 7;73(2):159-66. Přejít k původnímu zdroji...
    27. Maas B, Fairbairn N, Kerr T, Li K, Montaner JS, Wood E. Neighborhood and HIV infection among IDU: place of residence independently predicts HIV infection among a cohort of injection drug users. Health Place. 2007 Jun;13(2):432-9. Přejít k původnímu zdroji... Přejít na PubMed...
    28. Forrester JE. Nutritional alterations in drug abusers with and without HIV. Am J Infect Dis. 2006;2(3):173-9. Přejít k původnímu zdroji...
    29. Belak Kovačević S. Stress and facing among injecting drug users. Zagreb: Psychology Department, Faculty of Humanities and Social Sciences, University of Zagreb; 2004. (In Croatian.)
    30. Choi SY, Cheung YW, Chen K. Gender and HIV risk behavior among intravenous drug users in Sichuan Province, China. Soc Sci Med. 2006 Apr;62(7):1672-84. Přejít k původnímu zdroji... Přejít na PubMed...
    31. Bruneau J, Lamothe F, Soto J, Lachance N, Vincelette J, Vassal A, et al. Sex-specific determinants of HIV infection among injection drug users in Montreal. CMAJ. 2001 Mar 20;164(6):767-73. Přejít na PubMed...
    32. Patrick DM, Tyndall MW, Cornelisse PG, Li K, Sherlock CH, Rekart ML, et al. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ. 2001 Oct 2;165(7):88995.
    33. WHO, UNODC, UNAIDS Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users [Internet]. Geneva: WHO; 2009 [cited 2009 Jun 2]. Available from: http://www.who.int/hiv/pub/idu/targetsetting/en.
    34. Muga R, Sanvisens A, Bolao F, Tor J, Santesmases J, Pujol R, et al. Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 19872001. Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S29-33. Přejít k původnímu zdroji...
    35. Kerr T, Wood E, Small D, Palepu A, Tyndall MW. Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside. CMAJ. 2003 Oct 14;169(8):759-63. Přejít na PubMed...
    36. Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? CMAJ. 2001 Aug 21;165(4):405-10. Přejít na PubMed...
    37. Copenhaver MM, Johnson BT, Lee IC, Harman JJ, Carey MP; SHARP Research Team. Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J Subst Abuse Treat. 2006 Sep;31(2):163-71. Přejít k původnímu zdroji... Přejít na PubMed...
    38. Bealanger D, Godin G, Alary M, Bernard PM. Factors explaining the intention to use condoms among injecting drug users participating in a needle-exchange program. J Appl Soc Psychol. 2002 May;32(5):104763. Přejít k původnímu zdroji...
    39. Su NY, Lee SH. Estimating the population size and colony boundary of subterranean termites by using the density functions of directionally averaged capture probability. J Econ Entomol. 2008 Apr;101(2):592-604. Přejít k původnímu zdroji... Přejít na PubMed...
    40. Wiessing L, van de Laar MJ, Donoghoe MC, Guarita B, Klempová D, Griffiths P. HIV among injecting drug users in Europe: increasing trends in the East. Euro Surveill. 2008 Dec 11;13(50):pii 19067. Přejít k původnímu zdroji...
    41. You N, Xuan Mao C. Population size estimation in a two-list surveillance system with a discrete covariate. Biometrics. 2008 Jun;64(2):371-6. Přejít k původnímu zdroji... Přejít na PubMed...

    Zpět na obsah